Dopo l'orario di chiusura: 39.80

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie

Jump Financial LLC Buys New Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

A company insider recently sold 2092 shares of Xenon Pharmaceuticals Inc [XENE]. Should You Sale? – Knox Daily - Knox Daily

Wedbush Reiterates Xenon Pharmaceuticals (XENE) Outperform Recommendation - MSN

Did Xenon Pharmaceuticals Inc (XENE) perform well in the last session? – US Post News - US Post News

Daily Market Movement: Xenon Pharmaceuticals Inc (XENE) Sees a -0.27 Decrease, Closing at 40.34 – DWinneX - The Dwinnex

Natixis Advisors L.P. Sells 731 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Swiss National Bank Has $5.70 Million Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Xenon Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XENE) - MarketBeat

Nicholas Investment Partners LP Has $4.04 Million Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

(XENE) On The My Stocks Page - Stock Traders Daily

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Rating Reaffirmed by Needham & Company LLC - Defense World

Brokerages Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) PT at $59.11 - MarketBeat

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down Following Analyst Downgrade - Defense World

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript - Insider Monkey

Xenon Pharmaceuticals (NASDAQ:XENE) Shares Gap Down Following Analyst Downgrade - MarketBeat

Citigroup Lowers Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $60.00 - MarketBeat

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript - Insider Monkey

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus - MSN

Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus - Yahoo Finance

Xenon Pharmaceuticals (NASDAQ:XENE) Given Buy Rating at Needham & Company LLC - MarketBeat

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update - Financial Post

Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals: Q1 Earnings Snapshot - Houston Chronicle

Xenon Pharmaceuticals to Highlight Advances at Health Care Conference - TipRanks.com - TipRanks

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 - Financial Post

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 - The Globe and Mail

Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024

Xenon Pharmaceuticals (XENE) Set to Announce Earnings on Thursday - Defense World

Xenon Pharmaceuticals (XENE) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Movies Canada

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Purchased by TimesSquare Capital Management LLC - MarketBeat

Xenon Pharmaceuticals Spotlight at Global Healthcare Conference - TipRanks.com - TipRanks

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock - Zacks Investment Research

What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock

Are You Looking for a Top Momentum Pick? Why Xenon Pharmaceuticals (XENE) is a Great Choice - Yahoo Movies UK

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Analysts Just Trimmed Their Revenue Forecasts By 10% - Yahoo New Zealand News

Xenon Pharmaceuticals Unveils Q1 2024 Results - TipRanks.com - TipRanks

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and ... - Financial Post

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update

Investors Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat

abrdn plc Takes $1.48 Million Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat

Federated Hermes Inc. Invests $15.96 Million in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting - Quantisnow

Xenon Pharma to Spotlight Innovations at Investor Conference - TipRanks.com - TipRanks

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference - Investing.com UK

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference - Investing.com South Africa

Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference

Xenon Pharmaceuticals is Now Oversold (XENE) - Nasdaq

Simile a XENE